0001209191-12-022329.txt : 20120405
0001209191-12-022329.hdr.sgml : 20120405
20120405163234
ACCESSION NUMBER: 0001209191-12-022329
CONFORMED SUBMISSION TYPE: 4
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20120403
FILED AS OF DATE: 20120405
DATE AS OF CHANGE: 20120405
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: FINKELSTEIN J J
CENTRAL INDEX KEY: 0001125610
FILING VALUES:
FORM TYPE: 4
SEC ACT: 1934 Act
SEC FILE NUMBER: 001-15070
FILM NUMBER: 12746030
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: REGENERX BIOPHARMACEUTICALS INC
CENTRAL INDEX KEY: 0000707511
STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834]
IRS NUMBER: 521253406
STATE OF INCORPORATION: DE
FISCAL YEAR END: 1231
BUSINESS ADDRESS:
STREET 1: 3 BETHESDA METRO CENTER
STREET 2: SUITE 700
CITY: BETHESDA
STATE: MD
ZIP: 20814
BUSINESS PHONE: 3019611992
MAIL ADDRESS:
STREET 1: 3 BETHESDA METRO CENTER
STREET 2: SUITE 700
CITY: BETHESDA
STATE: MD
ZIP: 20814
FORMER COMPANY:
FORMER CONFORMED NAME: ALPHA 1 BIOMEDICALS INC
DATE OF NAME CHANGE: 19950719
4
1
doc4.xml
FORM 4 SUBMISSION
X0305
4
2012-04-03
0
0000707511
REGENERX BIOPHARMACEUTICALS INC
RGRX
0001125610
FINKELSTEIN J J
C/O REGENERX BIOPHARMACEUTICALS, INC.
15245 SHADY GROVE ROAD, SUITE 470
ROCKVILLE
MD
20850
1
1
0
0
President and CEO
Stock Option (right to buy)
0.16
2012-04-03
4
A
0
35000
0.00
A
2019-04-03
Common Stock
35000
35000
D
The shares underlying this option vest in full on June 30, 2012, subject to the reporting person's continued service with the issuer.
/s/ J.J. Finkelstein
2012-04-05